## Abstract DNA damage by agents crosslinking the strands presents a formidable challenge to the cell to repair for survival and to repair accurately for maintenance of genetic information. It appears that repair of DNA crosslinks occurs in a path involving double strand breaks (DSBs) in the DNA. M
Translesion DNA synthesis polymerases in DNA interstrand crosslink repair
✍ Scribed by The Vinh Ho; Orlando D. Schärer
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 560 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0893-6692
- DOI
- 10.1002/em.20573
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
DNA interstrand crosslinks (ICLs) are induced by a number of bifunctional antitumor drugs such as cisplatin, mitomycin C, or the nitrogen mustards as well as endogenous agents formed by lipid peroxidation. The repair of ICLs requires the coordinated interplay of a number of genome maintenance pathways, leading to the removal of ICLs through at least two distinct mechanisms. The major pathway of ICL repair is dependent on replication, homologous recombination, and the Fanconi anemia (FA) pathway, whereas a minor, G0/G1‐specific and recombination‐independent pathway depends on nucleotide excision repair. A central step in both pathways in vertebrates is translesion synthesis (TLS) and mutants in the TLS polymerases Rev1 and Pol ζ are exquisitely sensitive to crosslinking agents. Here, we review the involvement of Rev1 and Pol ζ as well as additional TLS polymerases, in particular, Pol η, Pol κ, Pol ι, and Pol ν, in ICL repair. Biochemical studies suggest that multiple TLS polymerases have the ability to bypass ICLs and that the extent ofbypass depends upon the structure as well as the extent of endo‐ or exonucleolytic processing of the ICL. As has been observed for lesions that affect only one strand of DNA, TLS polymerases are recruited by ubiquitinated proliferating nuclear antigen (PCNA) to repair ICLs in the G0/G1 pathway. By contrast, this data suggest that a different mechanism involving the FA pathway is operative in coordinating TLS in the context of replication‐dependent ICL repair. Environ. Mol. Mutagen., 2010. © 2010 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Mitomycin C (MMC) is a DNA crosslinking agent from human Xeroderma Pigmentosum (XP) complethat is used in cancer chemotherapy. Unlike the mentation group A and E cell lines, and a Fanconi's DNA crosslinks formed by cisplatin or psoralen, Anemia cell line were also examined. The UV-20 which significa
## Abstract Host cell reactivation assay using Trioxsalen‐crosslinked plasmid pEGFP‐N1 showed that human cells were able to repair Trioxsalen interstrand crosslinks (ICL). To study the mechanism of this repair pathway, cells were transfected with the plasmids pEGFP‐1, which did not contain the prom